Conrif DS 0.2% (Ophthalmic Solution)

5 ml drop: ৳ 150.00

Medicine Details

Category Details
Generic Olopatadine hydrochloride
Company Globe pharmaceuticals ltd
Also available as
Conrif 01 eye drop

Title

  • Patadin Eye Drops

Categories

  • Medicine
  • Ophthalmic Drugs
  • Allergy Relief
  • Nasal Spray
  • Tablet

Description

  • Indicated for the treatment of allergic conjunctivitis
  • Olopatadine is an antihistamine
  • Works by blocking the action of histamine
  • Available in different strengths (0.1%, 0.2%, 0.7%)
  • Can be administered in both eyes
  • Dosage depends on the severity of symptoms
  • Dosage forms include eye drops, nasal spray, and tablet
  • Instructions for using nasal spray
  • Instructions for cleaning nasal spray
  • Contraindications for hypersensitivity
  • Potential side effects like headache, blurred vision, and nausea
  • Use in pregnancy and lactation should be cautious
  • Precautions for wearing contact lenses
  • Storage conditions

Strength

  • 0.1%
  • 0.2%
  • 0.7%

Dosage Forms

  • Eye Drops
  • Nasal Spray
  • Tablet

Dosage Instructions

  • 0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours
  • 0.2%: One drop in the affected eye once a day
  • 0.7%: One drop in each affected eye once a day
  • Nasal Spray: Administer by the intranasal route only
  • Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily
  • Children 6 to 11 years of age: One spray per nostril twice daily
  • Tablet: Adults- 1 tablet (5 mg) twice daily, Children 7 years old or over- 1 tablet (5 mg) twice daily
  • If a dose is missed, the guidelines for taking the missed dose

AdministrationInstructions

  • Instructions for administering nasal spray and cleaning the device

ModeOfAction

  • Works by blocking the action of histamine in the body
  • Stabilizes mast cells and inhibits the release of histamine

Pharmacokinetics

  • Absorption occurs within 30 minutes to 1 hour
  • Moderate protein binding in human serum
  • Mainly eliminated through urinary excretion
  • Plasma elimination half-life: 8 to 12 hours

DrugInteractions

  • No formal drug-drug interaction studies conducted for nasal spray
  • Inhibitors of liver enzymes not anticipated to have drug interactions

Contraindications

  • Hypersensitivity to any component of the product
  • Allergic to olopatadine

SideEffects

  • Rarely headaches reported
  • Other adverse effects like asthenia, blurred vision, burning or stinging

PregnancyAndLactation

  • Not teratogenic in rats and rabbits
  • Limited studies in pregnant women, use in pregnancy only if potential benefit justifies risk

PrecautionsAndWarnings

  • Advised not to wear contact lens if the eye is red
  • Avoid using to treat contact lens related irritation
  • Instructions for use of nasal spray
  • Advice regarding the use of Olonex Tablets

PediatricUse

  • No overall differences in safety or effectiveness observed

Overdose

  • No information on Conrif DS overdose
  • Excessive use of any medication can have serious consequences

TherapeuticClass

  • Ophthalmic Non-Steroid drugs

StorageConditions

  • Store at room temperature
  • Protect from light
  • Do not use more than one month after first opening

Related Brands